Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study.

Hannah SongConnie S ZhongMark W KieranSusan N ChiKaren D WrightJennifer T Huang

Published in: Pediatric blood & cancer (2019)

Cutaneous reactions to targeted anticancer therapy in children are common, treatable, and rarely require drug dose reduction or discontinuation. Routine surveillance and early intervention may improve quality of life and facilitate continuation of life-saving therapy.

Keyphrases

young adults
randomized controlled trial
public health
emergency department
physical activity
risk factors
cancer therapy
blood brain barrier
drug delivery
drug induced